Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in MLL-rearranged Acute Leukemias
NCT02310243Phase 2Unknown
- Sponsor
- Ulm University
- Start
- Jul 2015
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Ulm University. Status: unknown.
02
Drugs
palbociclib
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02310243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02310243.